NAGE earnings date and last-quarter result: last quarter beat, P/E 14.49. Updated 2026-07-23.
Niagen Bioscience (NAGE) Research Hub
Niagen Bioscience (NAGE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.44 USD (+0.41%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 14.49, market cap 0.27B. This hub links to the full technical, earnings and options research available for NAGE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.44 USD (+0.41%) |
| 52-week range | 2.38 USD – 3.64 USD |
| Trend regime | Range |
| 14-day RSI | 30.2 (Bearish) |
| Trailing P/E | 14.49 |
| Market cap | 0.27B |
| Dividend yield | 0.00% |
Available research for NAGE
Covered Call on NAGE: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NAGE: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NAGE: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
NAGE technical analysis: range, last 2.44 USD, RSI 30.2, 52w range 2.38 USD–3.64 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NAGE in?
Niagen Bioscience (NAGE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NAGE in an uptrend or downtrend?
As of 2026-10-26, NAGE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NAGE's trailing P/E ratio?
NAGE's trailing P/E is 14.49, with a market cap of 0.27B. See the earnings research page for full valuation detail.